Skip to main content
Log in

Update on Transcatheter Aortic Valve Implantation

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Aortic stenosis affects a significant number of patients worldwide, and carries a dismal prognosis once symptoms develop. Unfortunately, a large number of patients present a prohibitive risk for surgical aortic valve replacement. Therefore, transcatheter aortic valve implantation has emerged as a promising technology for providing treatment to this group of patients. Currently available valves include the balloon-expandable Edwards SAPIEN valve (Edwards Lifesciences, Irvine, CA), which is usually implanted via a transfemoral or transapical approach, and the self-expanding CoreValve ReValving system (Medtronic, Minneapolis, MN), which uses only the transfemoral route. Early experience with the procedure performed on a compassionate-use basis was encouraging, and led to a number of first-in-man and feasibility studies. These trials demonstrated the safety and efficacy of valve implantation and led to CE (European Conformity) mark approval of both valves in Europe. Use of the SAPIEN valve in the United States is limited to the recently completed PARTNER (Placement of Aortic Transcatheter Valve) randomized trial comparing transcatheter and surgical aortic valve replacement in high-risk patients, and its post-trial registry. The CoreValve is not yet available in the United States. With improved device technology, better understanding of patient selection and pre- and periprocedural imaging, and greater procedural experience, widespread diffusion of transcatheter aortic valve implantation is expected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

I-REVIVE:

Initial Registry of Endovascular Implantation of Valves in Europe

PARTNER:

Placement of Aortic Transcatheter Valve

RECAST:

Registry of Endovascular Critical Aortic Stenosis Treatment

REVIVAL-II:

Transcatheter Endovascular Implantation of Valves II

REVIVE II:

Registry of Endovascular Implantation of Valves in Europe II

SOURCE:

A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards Sapien Valve

TRAVERCE:

Trans-Apical Surgical Delivery of the Cribier-Edwards Aortic Bioprosthesis Clinical Feasibility.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Nkomo VT, Gardin JM, Skelton TN, et al.: Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005–1011.

    Article  PubMed  Google Scholar 

  2. Carabello BA: Clinical practice. Aortic stenosis. N Engl J Med 2002, 346:677–682.

    Article  PubMed  Google Scholar 

  3. Iung B, Cachier A, Baron G, et al.: Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005, 26:2714–2720.

    Article  PubMed  Google Scholar 

  4. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al.: To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999, 82:143–148.

    CAS  PubMed  Google Scholar 

  5. Otto CM, Mickel MC, Kennedy JW, et al.: Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994, 89:642–650.

    CAS  PubMed  Google Scholar 

  6. Osswald BR, Gegouskov V, Badowski-Zyla D, et al.: Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009, 30:74–80.

    Article  PubMed  Google Scholar 

  7. Iung B, Himbert D, Vahanian A: A step forward in the evaluation of transcatheter aortic valve implantation. J Am Coll Cardiol 2010, 55:1091–1092.

    Article  PubMed  Google Scholar 

  8. Tuzcu EM, Kapadia SR, Schoenhagen P: Multimodality quantitative imaging of aortic root for transcatheter aortic valve implantation: more complex than it appears. J Am Coll Cardiol 2010, 55:195–197.

    Article  PubMed  Google Scholar 

  9. John D, Buellesfeld L, Yuecel S, et al.: Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010, 3:233–243.

    Article  PubMed  Google Scholar 

  10. Akhtar M, Tuzcu EM, Kapadia SR, et al.: Aortic root morphology in patients undergoing percutaneous aortic valve replacement: evidence of aortic root remodeling. J Thorac Cardiovasc Surg 2009, 137:950–956.

    Article  PubMed  Google Scholar 

  11. Messika-Zeitoun D, Serfaty JM, Brochet E, et al.: Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010, 55:186–194.

    Article  PubMed  Google Scholar 

  12. Nietlispach F, Leipsic J, Al-Bugami S, et al.: CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement. Swiss Med Wkly 2009, 139:458–462.

    PubMed  Google Scholar 

  13. Zajarias A, Cribier AG: Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009, 53:1829–1836.

    Article  PubMed  Google Scholar 

  14. Cribier A, Eltchaninoff H, Bash A, et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006–3008.

    Article  PubMed  Google Scholar 

  15. Cribier A, Eltchaninoff H, Tron C, et al.: Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004, 43:698–703.

    Article  PubMed  Google Scholar 

  16. Webb JG, Chandavimol M, Thompson CR, et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 113:842–850.

    Article  PubMed  Google Scholar 

  17. Lichtenstein SV, Cheung A, Ye J, et al.: Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006, 114:591–596.

    Article  PubMed  Google Scholar 

  18. Grube E, Schuler G, Buellesfeld L, et al.: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69–76.

    Article  PubMed  Google Scholar 

  19. Fraccaro C, Napodano M, Tarantini G, et al.: Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv 2009, 2:828–833.

    Article  PubMed  Google Scholar 

  20. Ruge H, Lange R, Bleiziffer S, et al.: First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report. Heart Surg Forum 2008, 11:E323–E324.

    Article  PubMed  Google Scholar 

  21. Schaechinger V: Results from The PARTNER EU Trial: Primary Endpoint Analysis. Presented at the EuroPCR. Barcelona, Spain; May 19–22, 2009.

  22. • Piazza N, Grube E, Gerckens U, et al.: Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008, 4:242–249. This paper discusses the results of a large, contemporary series of patients undergoing TAVI using the CoreValve ReValving system.

    PubMed  Google Scholar 

  23. Cribier A, Eltchaninoff H, Tron C, et al.: Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006, 47:1214–1223.

    Article  PubMed  Google Scholar 

  24. • Rodes-Cabau J, Webb JG, Cheung A, et al.: Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010, 55:1080–1090. This paper discusses the recently published Canadian experience of TF and TA TAVI.

    Article  PubMed  Google Scholar 

  25. • Masson JB, Kovac J, Schuler G, et al.: Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009, 2:811–820. This is a comprehensive review of complications encountered with TAVI.

    Article  PubMed  Google Scholar 

  26. Kapadia SR, Svensson L, Tuzcu EM: Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2009, 73:966–972.

    Article  PubMed  Google Scholar 

  27. Babaliaros V: Presented at the American College of Cardiology’s 59th Annual Scientific Session and i2 Summit. Atlanta, GA; March 14–16, 2010.

  28. Svensson LG, Dewey T, Kapadia S, et al.: United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008, 86:46–54; discussion 54–55.

    Article  PubMed  Google Scholar 

  29. Webb JG, Pasupati S, Humphries K, et al.: Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007, 116:755–763.

    Article  PubMed  Google Scholar 

  30. theheart.org: FRANCE: Transcatheter-valve registry permits "observation" of CoreValve, Sapien differences. Available at http://www.theheart.org/article/1021541.do. Accessed December 7, 2009.

  31. Piazza N, Onuma Y, Jesserun E, et al.: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008, 1:310–316.

    Article  PubMed  Google Scholar 

  32. Andersen HR, Knudsen LL, Hasenkam JM: Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13:704–708.

    CAS  PubMed  Google Scholar 

  33. theheart.org: Low 30-day and six-month mortality for transfemoral valve implantation in PARTNERS EU and SOURCE. Available at http://www.theheart.org/article/910857.do. Accessed November 2, 2009.

  34. Walther T, Simon P, Dewey T, et al.: Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007, 116(11 Suppl):I240–I245.

    PubMed  Google Scholar 

  35. Grube E, Laborde JC, Zickmann B, et al.: First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005, 66:465–469.

    Article  PubMed  Google Scholar 

  36. Grube E, Laborde JC, Gerckens U, et al.: Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006, 114:1616–1624.

    Article  PubMed  Google Scholar 

  37. Tamburino C, Capodanno D, Mule M, et al.: Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009, 21:93–98.

    PubMed  Google Scholar 

  38. Wenaweser P, Buellesfeld L, Gerckens U, Grube E: Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv 2007, 70:760–764.

    Article  PubMed  Google Scholar 

  39. Khawaja MZ, Haworth P, Ghuran A, et al.: Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol 2010, 55:97–101.

    Article  PubMed  Google Scholar 

  40. Ruiz CE, Laborde JC, Condado JF, et al.: First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Catheter Cardiovasc Interv 2008, 72:143–148.

    Article  PubMed  Google Scholar 

  41. Ussia GP, Mule M, Tamburino C: The valve-in-valve technique: transcatheter treatment of aortic bioprothesis malposition. Catheter Cardiovasc Interv 2009, 73:713–716.

    Article  PubMed  Google Scholar 

  42. Ng AC, van der Kley F, Delgado V, et al.: Percutaneous valve-in-valve procedure for severe paravalvular regurgitation in aortic bioprosthesis. JACC Cardiovasc Imaging 2009, 2:522–523.

    Article  PubMed  Google Scholar 

  43. Bruschi G, Demarco F, Oreglia J, et al.: Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis. J Cardiovasc Med (Hagerstown) 2010, 11:182–185.

    Google Scholar 

  44. Singh IM, Tuzcu EM, Shishehbor MH, et al.: Percutaneous treatment of aortic valve stenosis. Cleve Clin J Med 2008, 75:805–812.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amar Krishnaswamy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnaswamy, A., Tuzcu, E.M. & Kapadia, S.R. Update on Transcatheter Aortic Valve Implantation. Curr Cardiol Rep 12, 393–403 (2010). https://doi.org/10.1007/s11886-010-0126-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-010-0126-5

Keywords

Navigation